Loading clinical trials...
Loading clinical trials...
Lifestyle, Exercise and Nutrition (LEAN) Study 2
The specific aims of this study are to determine the efficacy and cost-effectiveness of a weight loss program compared with usual care (control) treatment on 6-month changes in body weight, body fat, serum hormones, and breast tissue markers associated with prognosis in breast cancer survivors.
We will conduct a two-armed study comparing a combination of an in-person and telephone weight loss program compared to usual care/wait list in 100 breast cancer survivors. Women will be randomized into one of the study arms using a random permuted block design. Research staff collecting body composition data, as well as reviewing forms and entering data, will be blinded to the participant's study group.
Age
18 - 75 years
Sex
FEMALE
Healthy Volunteers
No
Yale University
New Haven, Connecticut, United States
Start Date
November 1, 2013
Primary Completion Date
February 1, 2016
Completion Date
February 1, 2016
Last Updated
February 21, 2023
51
ACTUAL participants
Weight Loss Counseling
BEHAVIORAL
Lead Sponsor
Yale University
NCT05372640
NCT04704661
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions